The dietary flavonol quercetin ameliorates angiotensin II-induced redox signalling imbalance in a human umbilical vein endothelial cell model of endothelial dysfunction via ablation of p47(phox) expression
Abstract
Quercetin is reported to reduce blood pressure in hypertensive but not normotensive humans, but the role of endothelial redox signalling in this phenomenon has not been assessed. This study investigated the effects of physiologically-obtainable quercetin concentrations in a human primary cell model of endothelial dysfunction in order to elucidate the mechanism of action of its antihypertensive effects. Angiotensin II (100 nM, 8 h) induced dysfunction, characterised by suppressed nitric oxide availability (85 ± 4% p<0.05) and increased superoxide production (136 ± 5 %, p<0.001). These effects were ablated by an NADPH oxidase inhibitor. Quercetin (3 μM, 8 h) prevented angiotensin II induced changes in nitric oxide and superoxide levels, but no effect on upon nitric oxide or superoxide in control cells. The NADPH oxidase subunit p47(phox) was increased at the mRNA and protein levels in angiotensin II-treated cells (130 ± 14% of control, p<0.05), which was ablated by quercetin co-treatment. Protein kinase C activity was increased after angiotensin II treatment (136 ± 51%), however this was unaffected by quercetin co-treatment. Physiologically-obtainable quercetin concentrations are capable of ameliorating angiotensin II-induced end...Continue Reading
References
Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation.
Citations
Related Concepts
Related Feeds
Antihypertensive Agents: Mechanisms of Action
Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.